Mantle Cell Lymphoma  >>  granisetron intravenous  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
granisetron intravenous / Generic mfg.
NCT00450801: R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma

Completed
2
22
US
Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Cytarabine, AraC, Doxorubicin, Adriamycin, Etoposide, VP16, Ifosfamide, Ifex, Leucovorin, Folinic Acid, Methotrexate, amethopterin, Thalidomide, Thalomid, Vincristine, Oncovin, Mesna, Mesnex, Filgrastim (G-CSF), Neupogen, Granisetron, Sancuso, Granisol, Decadron, Maxidex, Ozurdex, Baycadron
University of Miami
Lymphoma
07/15
07/15

Download Options